Meta Platforms Inc. (NASDAQ: META) beats Q3-FY2026 Non-GAAP EPS analyst consensus of approx. $7.80–8.20 per share (earnings release approx. October 29, 2026, confirmed by Meta press release or Bloomberg)
Partial Hit
✦ AI-generated prediction
Published on 2. September 2026
·
Predicted for 29. October 2026
·
Based on: Historical Cycle
Meta has beaten Non-GAAP EPS consensus for ten consecutive quarters (FactSet). Q2 FY2026 (Aug 2026): adjusted EPS $8.33 vs. consensus $7.94 — a beat of +$0.39. Drivers: AI-powered Advantage+ ad booking system, growing Reels monetization, and disciplined cost management after the 'Year of Efficiency'. Bloomberg's seasonally adjusted consensus for Q3 is approx. $7.80–8.20 (mild advertising seasonality drag). FactSet ranks Meta as a top-5 EPS beater over the past eight quarters. Risk: EU Digital Markets Act fines, cyclical ad budget cuts.
Data basis for this prediction
- FactSet Earnings Insight: Meta – 10 aufeinanderfolgende Non-GAAP-EPS-Beats (Sep. 2026)
- Meta Investor Relations: Q2 FY2026 – bereinigtes EPS $8,33 vs. Konsens $7,94 (Aug. 2026)
- Bloomberg: Meta Q3 FY2026 EPS-Konsens ca. $7,80–8,20 (Stand Sep. 2026)
- Bloomberg: Meta Q3 FY2026 Ergebnisveröffentlichung geplant ca. 29. Oktober 2026
Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.
Verdict: Partial Hit
Meta berichtete Q3 2026 am 21. Oktober 2026 (nicht 29. Oktober). Non-GAAP EPS (bereinigt um die Rechtsstreit-Sonderbelastung) betrug 7,40 USD und übertraf damit den tatsächlichen Konsens von ca. 6,54 USD um +0,86 USD (+13,1 %) — die Beat-Richtung war korrekt. Jedoch lag der tatsächliche Non-GAAP EPS ($7,40) unter der prognostizierten Konsensrange von $7,80–$8,20. Ursache: Eine nicht antizipierte Sonderbelastung von 9,89 Mrd. USD aus dem August-2026-Vergleich mit US-Generalstaatsanwälten im Verfahren zur Jugend-Mental-Health-Klage drückte sowohl die Konsensschätzungen als auch die bereinigten Ergebnisse unter den prognostizierten Bereich. GAAP EPS lag bei nur 3,83 USD. Revenue (+26% YoY auf 64,6 Mrd. USD) und operative Werbe-KPIs (Ad-Impressions +10%, Preis/Ad +14%) waren stark. Quellen: SEC Form 8-K (meta-09302026), MarketBeat Q3 2026 Earnings Report, Yahoo Finance 'META Q3 Earnings Beat Estimates'.
💻 Technology
✦ AI
Applied Materials has beaten the EPS consensus in all four of its last reported quarters, with an average earnings surprise of +3.5%. The company's own Q4 guidance is $3.82–$4.22 per share; consensus at $4.06 sits near the midpoint, reflecting classic conservative management framing. Revenue is estimated at $10.30B (+51% YoY) — TSMC and Samsung have not pulled back H2 2026 capex plans. No Polymarket market directly available; a 100% beat streak over 4 quarters with a positive guidance range implies 70–75% probability. Risk: supply chain delays or expanded US export controls on advanced chips could force a Q5 inventory build.
💻 Technology
✦ AI
PLTR closed at $175.40 on November 4, 2026 (after-hours: $170.88, -2.58%; intraday high: $176.54; 52-week high: $212.94). Palantir clearly beat Q3-FY2026 EPS consensus: total revenue $2.313B, US Commercial revenue +148% YoY to $984M. The $185 threshold is +5.5% above the closing price or +8.3% above after-hours levels. Typical post-earnings 'sell the news' may weigh short-term, but the 52-week high of $212.94 confirms the level is reachable. NVIDIA earnings on November 18, 2026 could serve as a sector-wide catalyst. No direct Polymarket equivalent; own estimate: ~42%.
💻 Technology
✦ AI
CBRS trades at $109.18 (October 30, 2026) — already 61% below its all-time high of $279.72. The final and largest lockup expiration is scheduled for November 10, 2026: approximately 19.4 million shares are unlocked (of three tranches of 19.4M each). Prior lockup tranches have consistently weighed on the stock. Insiders have sold ~$394.6M in shares since the May 2026 IPO — zero insider purchases. A Culper Research short-seller report has triggered multiple investigations. A close below $100 requires a ~8.4% decline — plausible given the expected supply pressure on expiration day.